Last Updated on December 31, 2023 by The Health Master
Glenmark Pharma has been granted tentative approval by the US Food and Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%, the generic version of Enstilar Foam, 0.005%|0.064%, of Leo Pharma AS.
According to IQVIA sales data for the 12-month period ending March 2022, the Enstilar Foam 0.005% |0.064% market achieved annual sales of approximately $115.2 million.
USFDA gives tentative approval for this Hypertension drug
USFDA gives tentative nod to Zydus for Selexipag tablets
USFDA gives approval to Lupin Pregabalin capsules
USFDA gives final approval to Aleor Dermaceuticals for Docosanol cream
USFDA gives nod to these companies for Bortezomib for injection
USFDA grants approval for drug to treat spondylitis
FAQs – on Blood Bags and its Testing
USFDA gives tentative approval for this Hypertension drug
Man held in Internet pharmacy racket, Rs 3.17 cr cash seized
Man gets 10-years rigorous imprisonment for making drugs illegally
USFDA gives tentative nod to Zydus for Selexipag tablets
Govt releases guidelines on Pharma innovation and entrepreneurship for academic institutions
USFDA gives approval to Lupin Pregabalin capsules
Global drug development centre set up for APIs and Formulations
New molecule discovered that can be used for treatment of diabetes
Latest Notifications regarding Pharmaceuticals
